Advances in Hematopoietic Stem Cell Transplantation for Autoimmune Diseases

Yuxi Xu,Xiaoqi Wang,Ziyi Hu,Ruihao Huang,Guancui Yang,Rui Wang,Shijie Yang,Liyan Guo,Qingxiao Song,Jin Wei,Xi Zhang
DOI: https://doi.org/10.1016/j.heliyon.2024.e39302
IF: 3.776
2024-01-01
Heliyon
Abstract:Autoimmune diseases (ADs) are a collection of immunological disorders in which the immune system responds to self-antigens by producing autoantibodies or self-sensitized cells. Current treatments are unable to cure ADs, and achieving long-term drug-free remission remains a challenging task. Hematopoietic stem cell transplantation (HSCT) stands out from other therapies by specifically targeting ADs that target various cell subpopulations, demonstrating notable therapeutic benefits and resulting in sustained drug-free remission. Since different ADs have distinct mechanisms of action, the comprehensive understanding of how HSCT works in treating ADs is crucial. This review provides a detailed overview of the latest research and clinical applications of HSCT in treating ADs, offering new insights for clinicians aiming to optimize its use for ADs management.
What problem does this paper attempt to address?